(Q44523391)

3 December 2017

title

Increased in vitro cellular drug resistance is related to poor outcome in high-risk childhood acute lymphoblastic leukaemia (English)

1 reference

3 December 2017

1 reference

8

Kjeld Schmiegelow

1 reference

3 December 2017

9

Rolf Larsson

1 reference

3 December 2017

2

Peter Nygren

1 reference

3 December 2017

6

Jukka Kanerva

1 reference

3 December 2017

1

Britt-Marie Frost

1 reference

3 December 2017

4

Erik Forestier

1 reference

3 December 2017

3

Göran Gustafsson

1 reference

3 December 2017

10

Gudmar Lönnerholm

1 reference

Nordic Society for Paediatric Haematology and Oncology

3 December 2017

series ordinal

11

object named as

Nordic Society for Paediatric Haematology and Oncology

1 reference

3 December 2017

Olafur G Jonsson

5

1 reference

3 December 2017

Randi Nygaard

series ordinal

7

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

British Journal of Haematology

3 December 2017

published in

1 reference

3 December 2017

volume

122

1 reference

3 December 2017

issue

3

1 reference

3 December 2017

page(s)

376-385

1 reference

Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996. Nordic Society of Paediatric Haematology and Oncol

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04442.X

Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04442.X

In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04442.X

Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04442.X

Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04442.X

Chemotherapy of non-small cell lung carcinoma guided by an in vitro drug resistance assay measuring total tumour cell kill

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04442.X

Prognostic impact of karyotypic findings in childhood acute lymphoblastic leukaemia: a Nordic series comparing two treatment periods. For the Nordic Society of Paediatric Haematology and Oncology (NOPHO) Leukaemia Cytogenetic Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04442.X

Relationship between diagnosis-specific activity of cytotoxic drugs in fresh human tumour cells ex vivo and in the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04442.X

Risk assessment in acute lymphoblastic leukemia: beyond leukemia cell characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04442.X

Long-term results of large prospective trials in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04442.X

Pharmacokinetics of anticancer drugs in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04442.X

10.1046/J.1365-2141.2003.04442.X

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference